APAC
Kearney’s Dr Stephanie Allen: Health systems must pivot toward longevity and lifelong health
Kearney’s Dr Stephanie Allen: Health systems must pivot toward longevity and lifelong health
She discusses impactful healthcare innovations, partnerships, leadership qualities for scaling across markets, policy engagement, and preparing health systems for demographic shifts.
2 hours ago
Droppers market eyes $61.81b valuation by 2032
The Asia Pacific excluding Japan (APEJ) is expected to dominate overall market growth.
4 days ago
Demand for minimally invasive procedures to drive electrosurgical devices market to $10.2B by 2034
By region, the Asia-Pacific market is witnessing consistent expansion.
5 days ago
Hospital outsourcing to hit $1t as providers reduce cost
It is also being driven by staffing shortages, amongst others.
6 days ago
Pharmacy benefit management market nears $1t as chronic diseases rise
By region, the Asia Pacific region is expected to record the fastest growth.
6 days ago
Rising non‑invasive diagnostic demand drives 3D ultrasound market to $7.81b by 2034
It is being driven by the demand for non-invasive procedures.
Global diagnostic imaging equipment market to reach $51.5b by 2034
It will be driven by the prevalence of chronic conditions.
Lifestyle factors, heart disorders push fibrate market to $1.8b by 2034
APAC sees fibrates growth amidst urbanisation and healthcare spending.
Minimally invasive surgical devices market to reach $31b by 2034
The Asia Pacific region is expected to witness the fastest growth.
How do rising claims drive healthcare investment strategy?
Medical costs in Singapore and the Philippines may rise more than 16% this year.
Surgical robotics market to reach $30b by 2034
The Asia Pacific region is expected to witness the fastest growth.
Asian medical device markets face cost shocks amidst Iran conflict
The Strait of Hormuz is the chokepoint of the market.
Global dental articulators market to reach $227.8m by 2030
Growth is driven by ageing populations and new articulator designs.
Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034
Biotech investments fuel DNA manufacturing in Asia-Pacific.
Intelligent wound closure fuels surgical stapler market to $10.3b
The Asia-Pacific is emerging as the fastest-growing market.
Lipid nanoparticles market to reach $3.1b by 2033 as chronic diseases rise
The adoption of mRNA-based vaccines will also fuel demand.
Reproductive health disorders to drive female tech market to $26.1b by 2033
It will expand at a compound annual growth rate of 15.2%.
Most Read
1. Hospital outsourcing to hit $1t as providers reduce cost 2. China Biopharma’s $56.7b deal boom signals pillar industry dominance 3. Pharmacy benefit management market nears $1t as chronic diseases rise 4. Thailand agencies tighten disease surveillance in new health pact 5. Australia's digital health market set for 10% annual surge through 2035Resource Center
Read Here
Advertise
Sign Up
Events
Event News
She discusses impactful healthcare innovations, partnerships, leadership qualities for scaling across markets, policy engagement, and preparing health systems for demographic shifts.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation